State-Based Alternative Payment Models for Sickle Cell Disease


Opportunity ID: 320898
Opportunity Number: MP-CPI-20-002
Opportunity Title: State-Based Alternative Payment Models for Sickle Cell Disease
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.137
Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: All except Individuals, For profit Organization other than small business, and For profit Organizations other than small business Addition Eligibility: Private non-profit institutions of higher education; U.S. Territories
Agency Code: HHS-OPHS
Agency Name: Department of Health and Human Services
Office of the Assistant Secretary for Health
Posted Date: Sep 23, 2019
Last Updated Date: Sep 23, 2019
Estimated Synopsis Post Date: Dec 06, 2019
Fiscal Year: 2020
Award Ceiling: $2,500,000
Award Floor: $1,000,000
Estimated Total Program Funding: $2,500,000
Expected Number of Awards: 2
Description: With support from the Centers for Medicare & Medicaid Services (CMS), the HHS Office of Minority Health will offer a funding opportunity to develop an alternative payment model(s) for the care of patients with sickle cell disease (SCD) targeted for State Medicaid Offices, Medicaid Managed Care Organizations, and/or integrated health systems. A rigorous evaluation framework will be required to assess whether the alternative payment model(s) is associated with improved patient outcomes . This opportunity aligns with HHS Strategic Priority 4 to provide value-based care. BACKGROUND INFORMATION: SCD, estimated to affect 100,000 Americans, is the most common inherited blood disorder in the United States and is characterized by debilitating pain crises, frequent hospitalizations, and chronic end-organ damage. Clinical care for patients with SCD is variable. An estimated 60 to 70 percent of patients with SCD access care through State-based Medicaid plans. Alternative payment models (i.e., incentive-based models which increase provider reimbursements when benchmarks are met for quality measures) have been shown to improve care for other conditions (e.g., oncology care model) and might be effective for the SCD population.
Version: 1

Visit the Official Webpage For More Details on State-Based Alternative Payment Models for Sickle Cell Disease


Please enter your comment!
Please enter your name here